Most minority ethnic groups are less successful than their White British counterparts when applying to specialty training programmes in the NHS, Cambridge researchers have shown.
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.
Cambridge researchers are jointly leading the first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer.
From developing intensive care equipment to tackling supplies of PPE and oxygen, here's how a group of Cambridge researchers refocused and partnered with local hospitals during COVID-19.
Cambridge scientists have identified a drug that can be repurposed to prevent COVID-19 in research involving a unique mix of ‘mini-organs’, donor organs, animal studies and patients.
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke’s Hospital and the University of Cambridge has found.
Researchers say a ‘human bottleneck’, due to historical cuts in public health funding, delayed the UK’s scale-up of COVID-19 testing in the early stages of the country’s pandemic response.
Self-confessed ‘nerd’ Serena Nik-Zainal went from hospital wards to the laboratory on a mission to provide patients with the best possible treatment for their illnesses. Ten years later she is at the forefront of genomic research, creating tools for clinicians which are transforming patient care.
Men with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines and media health campaigns focus on urinary symptoms despite a lack of scientific evidence, say experts at the University of Cambridge.
A new partnership involving Cambridge University Hospitals (CUH) and the University’s Faculty of Education, brings medical training using 'mixed reality' technology one step closer. The project aims to make consistent, high-level and relevant clinical training more accessible across the world.
© 2026 University of Cambridge